HCV NS3 protease inhibitors

The present invention relates to hepatitis C virus (HCV) NS3 protease inhibitors containing a spirocyclic moeity, uses of such compounds, and synthesis of such compounds.

Saved in:
Bibliographic Details
Main Authors MIAO, SHOUWU, XIA, YAN, BISWAS, DIPSHIKA, JOSIEN, HUBERT, MARCANTONIO, KAREN, CHELIAH, MARIAPPAN, CLASBY, MARTIN, SHAH, UNMESH, BARA, THOMAS, RAJAGOPALAN, MURALI, CHACKALAMANNIL, SAMUEL, BHAT, SATHESH, HAN, YONGXIN, PINTO, PATRICK, BROCKUNIER, LINDA, GUO, ZHUYAN, CHEN, AUSTIN, VENKATARAMAN, SRIKANTH, JAYNE, CHARLES, BURNETTE, DUANE, NEELAMKAVIL, SANTHOSH, VELAZQUEZ, FRANCISCO, COLANDREA, VINCE
Format Patent
LanguageEnglish
Published 05.02.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to hepatitis C virus (HCV) NS3 protease inhibitors containing a spirocyclic moeity, uses of such compounds, and synthesis of such compounds.
Bibliography:Application Number: AU20130299807